#AIVF

AiVF raises $25 Million to transform fertility with the first operational AI-based IVF platform

Medical technology company poised to transform the fertility journey with the first operational AI platform.

AiVF study: genetic characteristics in embryos can be identified by non-invasive AI analysis

Daniella Gilboa, CEO and Co-Founder of AiVF: "This breakthrough scientific research concluded that AiVF's EMA™ platform can automatically and reliably determine an embryo's ploidy status i.e., whether it is genetically suitable, without the need for an invasive biopsy (PGT-A) or spent media analysis. A truly contactless PGT-A”

AiVF Receives European Approval for its Cutting Edge AI based IVF Treatments

This Israeli Startup is Using Deep Learning and Computer Vision to Revolutionize IVF Treatments